Rhone Ma Holdings Bhd
Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory servic… Read more
Market Cap & Net Worth: Rhone Ma Holdings Bhd (5278)
Rhone Ma Holdings Bhd (KLSE:5278) has a market capitalization of $33.72 Million (RM151.89 Million) as of March 19, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #31851 globally and #712 in its home market, demonstrating a -2.82% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Rhone Ma Holdings Bhd's stock price RM0.69 by its total outstanding shares 220128000 (220.13 Million).
Rhone Ma Holdings Bhd Market Cap History: 2016 to 2026
Rhone Ma Holdings Bhd's market capitalization history from 2016 to 2026. Data shows growth from $33.88 Million to $33.72 Million (1.30% CAGR).
Rhone Ma Holdings Bhd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Rhone Ma Holdings Bhd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.16x
Rhone Ma Holdings Bhd's market cap is 0.16 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
2.68x
Rhone Ma Holdings Bhd's market cap is 2.68 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $33.88 Million | $119.20 Million | $9.17 Million | 0.28x | 3.70x |
| 2017 | $34.48 Million | $137.49 Million | $13.91 Million | 0.25x | 2.48x |
| 2018 | $31.51 Million | $135.24 Million | $10.07 Million | 0.23x | 3.13x |
| 2019 | $28.73 Million | $119.06 Million | $8.64 Million | 0.24x | 3.33x |
| 2020 | $35.32 Million | $146.68 Million | $7.28 Million | 0.24x | 4.85x |
| 2021 | $32.96 Million | $169.43 Million | $11.27 Million | 0.19x | 2.93x |
| 2022 | $31.63 Million | $198.15 Million | $12.74 Million | 0.16x | 2.48x |
| 2023 | $32.53 Million | $202.93 Million | $12.08 Million | 0.16x | 2.69x |
| 2024 | $32.99 Million | $211.41 Million | $12.31 Million | 0.16x | 2.68x |
Competitor Companies of 5278 by Market Capitalization
Companies near Rhone Ma Holdings Bhd in the global market cap rankings as of March 19, 2026.
Key companies related to Rhone Ma Holdings Bhd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Rhone Ma Holdings Bhd Historical Marketcap From 2016 to 2026
Between 2016 and today, Rhone Ma Holdings Bhd's market cap moved from $33.88 Million to $ 33.72 Million, with a yearly change of 1.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM33.72 Million | 0.00% |
| 2025 | RM33.72 Million | +2.22% |
| 2024 | RM32.99 Million | +1.41% |
| 2023 | RM32.53 Million | +2.86% |
| 2022 | RM31.63 Million | -4.05% |
| 2021 | RM32.96 Million | -6.68% |
| 2020 | RM35.32 Million | +22.95% |
| 2019 | RM28.73 Million | -8.84% |
| 2018 | RM31.51 Million | -8.59% |
| 2017 | RM34.48 Million | +1.76% |
| 2016 | RM33.88 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Rhone Ma Holdings Bhd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $33.72 Million USD |
| MoneyControl | $33.72 Million USD |
| MarketWatch | $33.72 Million USD |
| marketcap.company | $33.72 Million USD |
| Reuters | $33.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.